Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

NCT03491033 · clinicaltrials.gov ↗
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University